Dumon, Mae Antonette D.
HRN: 08-19-75 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/19/2022
CEFUROXIME 500MG (TAB)
04/20/2022
04/26/2022
PO
500mg
BID X 7 Days
WBC: 18.8; S/p LTCS With IUD Insertion For Oligohydramnios; Overt DM-insulin Requiring (controlled)
Waiting Final Action
Indication: Empirical De-escalation Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes